RxDoctor Payments Data

Bradley Erickson, MD

Urology · Iowa City, IANPI 1164679262

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $44,100 of the $64,572 with a category attached, or 68.3%. Boston Scientific accounts for 79.9% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $28,956, more than ten times the $541 reported in 2019. Among urology clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$64,572in general payments, 2019–2025

Across 95 payments — averaging $679.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$52K
  • Endo USA, Inc.$11K
  • Coloplast$590
  • Cook Incorporated$581
  • Johnson & Johnson$124
  • Endo Pharmaceuticals Inc.$96
  • plus $177 from 2 others
$48,696in research payments, 2019–2025

Across 25 payments — averaging $1947.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$48K
  • Laborie Medical Technologies Corp.$879

What the payments were for

  • Consulting fees$10,71117%
  • Speaking & faculty fees$44,10068%
  • Travel & lodging$6,30210%
  • Food & beverage$3,3635%
  • Education$960%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$64,572 in reported general payments places this provider in the 95th percentile of 114 urology providers in Iowa.

See all urology providers in Iowa

Medicare billing

Part B allowed, 2024
$137,092
Medicare patients
266
Services billed
715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron20$12,818

Paid to pharmacies, not to this prescriber.

Other urology in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →